Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Are pertussis cases reported too late for public health interventions? Retrospective analysis of cases in London and South East England, 2010 to 2015.

Crabbe H, Saavedra-Campos M, Verlander NQ, Leonard A, Morris J, Wright A, Balasegaram S.

Euro Surveill. 2017 Jul 20;22(29). pii: 30577. doi: 10.2807/1560-7917.ES.2017.22.29.30577.

2.

Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: a systematic review.

Remschmidt C, Harder T, Wichmann O, Bogdan C, Falkenhorst G.

BMC Infect Dis. 2016 Nov 25;16(1):711. Review.

3.

What criteria do decision makers in Thailand use to set priorities for vaccine introduction?

Pooripussarakul S, Riewpaiboon A, Bishai D, Muangchana C, Tantivess S.

BMC Public Health. 2016 Aug 2;16:684. doi: 10.1186/s12889-016-3382-5.

4.

Varicella Vaccine Effectiveness in Preventing Community Transmission in the 2-Dose Era.

Perella D, Wang C, Civen R, Viner K, Kuguru K, Daskalaki I, Schmid DS, Lopez AS, Tseng HF, Newbern EC, Mascola L, Bialek SR.

Pediatrics. 2016 Apr;137(4). pii: e20152802. doi: 10.1542/peds.2015-2802. Epub 2016 Mar 14.

5.

Determinants of nonimmunization of children under 5 years of age in Pakistan.

Murtaza F, Mustafa T, Awan R.

J Family Community Med. 2016 Jan-Apr;23(1):32-7. doi: 10.4103/2230-8229.172231.

6.

Estimating rotavirus vaccine effectiveness in Japan using a screening method.

Araki K, Hara M, Sakanishi Y, Shimanoe C, Nishida Y, Matsuo M, Tanaka K.

Hum Vaccin Immunother. 2016 May 3;12(5):1244-9. doi: 10.1080/21645515.2015.1121337. Epub 2015 Dec 17.

7.

Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future.

Trombetta CM, Perini D, Mather S, Temperton N, Montomoli E.

Vaccines (Basel). 2014 Oct 13;2(4):707-34. doi: 10.3390/vaccines2040707. Review.

8.

Serological criteria and carriage measurement for evaluation of new pneumococcal vaccines.

Principi N, Esposito S.

Hum Vaccin Immunother. 2015;11(6):1494-500. doi: 10.1080/21645515.2015.1033600.

9.

Structural analysis of the synthetic Duffy Binding Protein (DBP) antigen DEKnull relevant for Plasmodium vivax malaria vaccine design.

Chen E, Salinas ND, Ntumngia FB, Adams JH, Tolia NH.

PLoS Negl Trop Dis. 2015 Mar 20;9(3):e0003644. doi: 10.1371/journal.pntd.0003644. eCollection 2015 Mar.

10.

Veterinary and human vaccine evaluation methods.

Knight-Jones TJ, Edmond K, Gubbins S, Paton DJ.

Proc Biol Sci. 2014 Apr 16;281(1784):20132839. doi: 10.1098/rspb.2013.2839. Print 2014 Jun 7. Review.

11.

Meningococcal serogroup A, C, W₁₃₅ and Y conjugated vaccine: a cost-effectiveness analysis in the Netherlands.

Hepkema H, Pouwels KB, van der Ende A, Westra TA, Postma MJ.

PLoS One. 2013 May 31;8(5):e65036. doi: 10.1371/journal.pone.0065036. Print 2013.

12.

Management of vaccine safety in Korea.

Choe YJ, Bae GR.

Clin Exp Vaccine Res. 2013 Jan;2(1):40-5. doi: 10.7774/cevr.2013.2.1.40. Epub 2013 Jan 15.

13.

Highlights of historical events leading to national surveillance of vaccination coverage in the United States.

Smith PJ, Wood D, Darden PM.

Public Health Rep. 2011 Jul-Aug;126 Suppl 2:3-12. No abstract available.

14.

Epidemiology of influenza-like illness during Pandemic (H1N1) 2009, New South Wales, Australia.

Muscatello DJ, Barr M, Thackway SV, Macintyre CR.

Emerg Infect Dis. 2011 Jul;17(7):1240-7. doi: 10.3201/eid1707.101173.

Supplemental Content

Support Center